Роль пресепсина в диагностике и оценке тяжести течения сепсиса и тяжелой пневмонии
| Autor: | E A TItova, Z A Titova, A R Eyrikh |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
History
medicine.medical_specialty business.industry Endocrinology Diabetes and Metabolism Inflammation General Medicine 030204 cardiovascular system & hematology medicine.disease Gastroenterology Sepsis 03 medical and health sciences Pneumonia 0302 clinical medicine Antibacterial therapy Abdominal sepsis Antibiotic therapy Internal medicine medicine Infectious disease (athletes) medicine.symptom Young adult Family Practice business 030217 neurology & neurosurgery |
| Zdroj: | Terapevticheskii arkhiv. 90:44-47 |
| ISSN: | 2309-5342 |
| DOI: | 10.26442/terarkh2018901144-47 |
| Popis: | The aim of this study was to evaluate marker of inflammation presepsin to improve diagnosis of severe pneumonia, sepsis. Materials and methods. 75 patients with pneumonia, sepsis, other inflammatory diseases aged from 17 to 78 years were examined. These patients have been investigated for the level of the presepsin. Presepsin level was quantified on immunohemilyuministsentny analyzer Pathfast (Mitsubishi Chemical Medience Corporation, Japan) in pg/ml. All patients had obtained an antibacterial therapy in other health care organizations before entering the hospital. Results. Presepsin at the general group of patients with pneumogenic sepsis was 3196.9±1202.16 pg/mL (n=14, x±m), with abdominal sepsis - 2506.7±448.32 pg/mL (n=28), with other inflammatory diseases - 671.6±124.55 pg/mL (n=11). Presepsin of patients with pneumogenic sepsis was 1125.3±240.59 pg/mL (n=3), presepsin of patients with severe pneumonia was - 362.6±76.29 pg/mL (n=13, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|